ADVERTISEMENT
Posted: Sep 7, 2024

Tirzepatide could be first drug used to treat sleep apnea

Sleep Apnea

Results from a June 21, 2024, NEJM study suggest that tirzepatide may be a potential treatment for the more than 900 million people worldwide affected by sleep apnea.

Lauren Howell, PharmD

Read more
Posted: Sep 7, 2024

Pharmacist-led CGM service improves outcomes, raises revenue

CGM

More than 38 million U.S. adults have diabetes, according to CDC. The American Diabetes Standards of Care 2024 recommends real-time or intermittently scanned CGM for people with diabetes who require multiple daily insulin injections or continuous subcutaneous insulin injections. 

Sonya Collins

Read more
Posted: Sep 7, 2024

FDA warning underscores risks of psychedelic-based products

Poison Control

In June 2024, FDA issued a nationwide warning regarding a ‘shroombased product that has been associated with at least 40 hospitalizations and potentially two deaths.

Elizabeth Briand

Read more
Posted: Sep 7, 2024

Creatine for strength, energy, and more

On The Shelf

Creatine is a very popular sports supplement among athletes and individuals seeking to enhance muscle growth, performance, and strength.

Mickie Cathers

Read more
Posted: Sep 7, 2024

Don’t let patients worry about warts

OTCs Today

Warts, or verrucae, are a common skin disorder caused by HPV. Fortunately, warts are considered benign and often resolve without treatment within a few months to a year.

Mary Warner

Read more
12

Related Articles

Advertisement
Advertisement
Advertisement
Advertisement
ADVERTISEMENT